Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 9/20 | 0.38 |
| ▸ | CCNT1 | O60563 | 8/20 | 0.38 |
| ▸ | GSK3B | P49841 | 2/20 | 0.37 |
| ▸ | GSK3A | P49840 | 1/20 | 0.37 |
| ▸ | ATR | Q13535 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 3/20 | 0.35 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26152085 | 1.00 | CDK9 (0.38) | CDK9CCNT1GSK3BGSK3AATR | |
| SCHEMBL30418690 | 1.00 | CDK9 (0.38) | CDK9CCNT1GSK3BGSK3AATR | |
| SCHEMBL25184331 | 0.89 | CDK9 (0.38) | CDK9CCNT1GSK3BGSK3AATR | |
| SCHEMBL26152084 | 0.87 | ABL1 (0.39) | CDK9CCNT1GSK3BGSK3AMAPT | |
| SCHEMBL26152245 | 0.83 | CDK9 (0.38) | CDK9CCNT1GSK3BGSK3AATR | |
| SCHEMBL30418688 | 0.83 | CDK9 (0.38) | CDK9CCNT1GSK3BGSK3AATR | |
| SCHEMBL29262974 | 0.81 | RORC (0.39) | CDK9CCNT1GSK3BGSK3AATR | |
| SCHEMBL31058906 | 0.81 | RORC (0.39) | CDK9CCNT1GSK3BGSK3AATR | |
| SCHEMBL26152105 | 0.81 | RORC (0.39) | CDK9CCNT1GSK3BGSK3AATR | |
| SCHEMBL30419249 | 0.79 | ATR (0.56) | ATR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118251389-A | Pyridyl derivatives as sodium channel activators | 泽农医药公司 | 2024-06-25 | — | — | CN | disclosed |